First human test: new drug meets common heart pills
NCT ID NCT07265466
Summary
This is an early safety study to see how a new drug, JP-1366, interacts with four common heart and blood clot medications (clopidogrel, aspirin, atorvastatin, and apixaban). It will involve 96 healthy volunteers to check if taking JP-1366 with these drugs is safe and to measure how the drugs affect each other in the body. The goal is to gather information for future research, not to treat a disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG DRUG INTERACTION (DDI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cha University Bundang Medical Center
RECRUITINGSeongnam-si, Gyeonggi-do, 13496, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.